Biotechnology: Pharmaceutical Preparations Stocks
436 biotechnology: pharmaceutical preparations stocks ranked by market capitalization, page 7 of 9. Updated October 11, 2026.
Today
+1.28%Biotechnology: Pharmaceutical Preparations stocks ranked 301–350
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 301 | KZIA | Kazia Therapeutics Limited ADR | 8.93 | +1.25% | 123.44K | $102.04M |
| 302 | ANIX | Anixa Biosciences Inc. | 2.90 | -0.34% | 217.88K | $100.82M |
| 303 | PDSB | PDS Biotechnology Corporation | 1.38 | +35.29% | 16.06M | $100.01M |
| 304 | PLYX | Polaryx Therapeutics Inc. | 2.00 | 0.00% | 10.96K | $99.69M |
| 305 | OKUR | OnKure Therapeutics Inc. Class A | 2.41 | +4.78% | 609.37K | $97.60M |
| 306 | RLYB | Rallybio Corporation | 17.02 | +0.18% | 6.94K | $90.42M |
| 307 | EQ | Equillium Inc. | 1.41 | -2.08% | 522.00K | $89.41M |
| 308 | PMN | ProMIS Neurosciences Inc. | 9.61 | +5.03% | 18.85K | $86.18M |
| 309 | RFL | Rafael Holdings Inc. Class B | 1.60 | +8.11% | 93.91K | $83.20M |
| 310 | TELO | Telomir Pharmaceuticals Inc. | 1.12 | -2.61% | 64.65K | $82.45M |
| 311 | ZYBT | Zhengye Biotechnology Holding Limited Class A | 1.73 | +50.45% | 30.60M | $81.99M |
| 312 | ACRV | Acrivon Therapeutics Inc. | 1.91 | +2.14% | 192.04K | $81.85M |
| 313 | NTHI | NeOnc Technologies Holdings Inc. | 2.78 | +9.88% | 165.85K | $80.08M |
| 314 | SDEV | Stablecoin Development Corporation | 1.54 | -22.61% | 15.18M | $79.70M |
| 315 | INCR | Intercure Ltd. | 5.17 | +2.99% | 484 | $77.57M |
| 316 | OSTX | OS Therapies Incorporated | 1.62 | 0.00% | 418.34K | $75.82M |
| 317 | LFVN | Lifevantage Corporation | 6.00 | +0.17% | 23.15K | $75.54M |
| 318 | MAIA | MAIA Biotechnology Inc. | 1.22 | +6.09% | 374.63K | $75.33M |
| 319 | MNOV | Medicinova Inc | 1.52 | -1.30% | 69.89K | $74.82M |
| 320 | NMAD | Nomad Power Solutions Inc. | 4.53 | +6.09% | 165.49K | $72.94M |
| 321 | GANX | Gain Therapeutics Inc. | 1.64 | +1.55% | 328.69K | $71.58M |
| 322 | FBIO | Fortress Biotech Inc. | 2.14 | +2.15% | 186.21K | $71.20M |
| 323 | CING | Cingulate Inc. | 4.89 | +0.20% | 27.84K | $71.11M |
| 324 | VRCA | Verrica Pharmaceuticals Inc. | 4.11 | -1.67% | 46.55K | $70.60M |
| 325 | HYFT | MindWalk Holdings Corp. | 1.50 | +4.55% | 238.91K | $70.43M |
| 326 | TENX | Tenax Therapeutics Inc. | 1.87 | +0.54% | 2.35M | $69.98M |
| 327 | SPRO | Spero Therapeutics Inc. | 1.20 | +5.26% | 439.18K | $69.88M |
| 328 | XBIT | XBiotech Inc. | 2.29 | +4.09% | 88.03K | $69.82M |
| 329 | PLRX | Pliant Therapeutics Inc. | 1.02 | +2.00% | 288.53K | $63.16M |
| 330 | APLM | Apollomics Inc. Class A | 21.50 | -0.92% | 8.79K | $62.67M |
| 331 | XLO | Xilio Therapeutics Inc. | 9.05 | +0.44% | 5.53K | $59.55M |
| 332 | BOLD | Boundless Bio Inc. | 2.53 | -1.94% | 166.79K | $58.47M |
| 333 | RNXT | RenovoRx Inc. | 1.28 | -3.76% | 798.79K | $57.77M |
| 334 | GOSS | Gossamer Bio Inc. | 9.31 | -5.77% | 291.00K | $56.94M |
| 335 | ATHE | Alterity Therapeutics Limited ADR | 3.12 | +1.47% | 22.66K | $56.72M |
| 336 | TLPH | Talphera Inc. | 1.08 | 0.00% | 64.65K | $56.06M |
| 337 | CLNN | Clene Inc. | 3.86 | -0.52% | 48.13K | $54.87M |
| 338 | ACET | Adicet Bio Inc. | 5.61 | -2.26% | 189.83K | $52.52M |
| 339 | HYPD | Hyperion DeFi Inc. | 3.40 | +1.04% | 217.18K | $51.69M |
| 340 | ANVS | Annovis Bio Inc. | 1.21 | +3.42% | 521.86K | $51.64M |
| 341 | SER | Serina Therapeutics Inc. | 2.00 | -0.50% | 22.27K | $50.80M |
| 342 | CELU | Celularity Inc. Class A | 1.56 | +6.85% | 53.20K | $50.62M |
| 343 | ELTX | Elicio Therapeutics Inc. | 1.89 | +4.42% | 306.19K | $49.67M |
| 344 | CRVO | CervoMed Inc. | 3.22 | -1.83% | 237.33K | $48.68M |
| 345 | DWTX | Dogwood Therapeutics Inc. | 1.40 | -0.71% | 66.32K | $47.59M |
| 346 | EDSA | Edesa Biotech Inc. | 3.51 | -4.10% | 36.47K | $47.43M |
| 347 | GRCE | Grace Therapeutics Inc. | 2.08 | +1.96% | 37.79K | $43.75M |
| 348 | VERU | Veru Inc. | 2.46 | +1.65% | 128.90K | $41.94M |
| 349 | NSRX | Nasus Pharma Ltd. | 3.51 | -3.31% | 15.82K | $41.12M |
| 350 | SCYX | SCYNEXIS Inc. | 4.08 | -3.32% | 120.05K | $40.59M |
Explore more
Prices as of Oct 11, 5:10 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer